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This study was carried out to determine the correlation between urine 
proteins and urinary enzyme markers, aspartate aminotransferase (AST), y- 
glutamyl transferase (y-GT) and alkaline phosphatase (ALP) and tissue 
histopathological changes during early renal damage induced by gentamicin. 
Fifty five Sprague-Dawley rats, aged 7-8 weeks old were divided into two 
groups. One group of ten rats served as controls and forty-five rats were 
treated with gentamicin intraperitoneally to induce renal damage. Twenty four 
hour urine samples were collected daily for 3 days. On the third day, blood 
was withdrawn through cardiac puncture and kidney tissues from sacrificed 
rats were taken for histopathological analysis. Urine proteins were separated 
by sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS- 
PAGE). Concentration of urine proteins, enzymes, serum urea nitrogen 
(BUN) and creatinine were analysed using a chemistry analyser. The 
SDS-PAGE of urine proteins showed that proteinuria in gentamicin-treated 
rats consisted primarily of protein with low molecular weight. The separated 
urine proteins were mainly located in the molecular weight range of 10 to > 
70 kDa. An extra protein band with molecular weight estimated to be 
approximately 11 kDa was also detected in the gentamicin-treated group and 
suggested to be an indicator of early renal disease. The electrophoretic 
patterns of urine proteins also demonstrated that the type of proteins leaking 
into urine had also provided some insight on the location and degree of renal 
injury. High urine enzymes concentrations specifically ALP had also reflected 
that the onset of injury was in the renal proximal tubular cells. This was 
confirmed by renal tissue histopathological evidences. Each parameter 
showed a high grading in gentamicin-treated group. Grade 3 cytoplasmic 
vacuolization (31%), grade 3 tubular dilatation (33.3%) and grade 3 cell 
detachment (33.3%) were the most prominent morphological changes in that 
group. BUN and serum creatinine did not show any obvious difference 
between the two groups. In conclusion, the elevated concentrations of low 
molecular weight urine proteins and urine enzymes appeared to be useful 
indicators for early renal damage as their elevation occurred before the BUN 
and serum creatinine produced any change. 
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Kajian ini dijalankan untuk menentukan perkaitan di antara protein urin dan 
penanda enzim urin, aspartat aminotransferase (AST), -glutamil transferase 
- -  .(-GT), dan alkalin fosfatase (ALP) dengan perubahan histopatologi dalam . 
kerosakan renal awal yang diaruh oleh gentamisin. Lima puluh lima ekor 
tikus Sprague-Dawley, berumur 7-8 minggu, telah dibahagikan kepada dua 
kumpulan. Kumpulan pertama dengan sepuluh ekor tikus bertindak sebagai 
kawalan, dan empat puluh lima ekor lagi diperlakukan dengan gentamisin 
secara suntikan intraperitoneum untuk mengaruhkan kerosakan ginjal. 
Sampel dua puluh empat jam urin telah diambil setiap hari selama tiga hari. 
Pada hari ketiga darah &paolehi melaluiucdan kardiwrt dantktt ginjat 
daripada tikus yang telah dimatikan diperolehi untuk analisis histopatologi. 
Protein urin diasingkan melalui elektroforesis agar-agar natrium dodesil sulfat 
-poliakrilamida (SDS-PAGE). Kepekatan protein and enzim urin, 
nitrogen urea darah (BUN) dan kreatinina serum telah dianalisis 
mengguna penganalisis kimia. SDS-PAGE untuk protein urin menunjukkan 
proteinuria dalam tikus terperlaku gentamisin terdiri terutama sekali daripada 
protein berat molekul rendah. Protein yang terasing itu terletak khususnya 
pada julat berat molekul 10 hingga >70 kDa. Satu lagi jalur protein yang 
berat molekulnya dianggar pada lebih kurang 11 kDa telah dikesan dalam 
kumpulan terperlaku gentamisin dan ini disarankan sebagai petunjuk kepada 
penyakit gingal awal. Pola elektroforesis protein urin telah menunjukkan 
yang jenis protein yang terkeluar kepada urin telah memberi gambaran 
kepada tahap dan tempat berlakunya kecederaan renal. Kepekatan enzim 
urin tinggi, khususnya ALP telah mencerminkan yang kecederaan mula 
tercetus pada sel tubul proksimal renal. Ini telah terbukti pada histopatologi 
tisu renal. Setiap parameter menunjukkan gred yang tinggi bagi kumpulan 
yang disuntik gentamisin. Gred 3 vakulisasi sitoplama (31%), gred 3 dilatasi 
tubul (33.3%) dan gred 3 penanggalan sel (33.3%) merupakan perubahan- 
perubahan morfologi yang ketara ditunjukkan oleh kumpulan tersebut. BUN 
dan kreatinina serum tidak menunjukkan sebarang kelainan yang jelas di 
antara kumpulan. Adalah disimpulkan yang peningkatan kepekatan protein 
berat molekul rendah dan enzim urin merupakan petunjuk berguna dalam 
kerosakan renal awal kerana peningkatannya berlaku sebelum ada sebarang 
perubahan dalam BUN dan serum kreatinina. 
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CHAPTER l 
INTRODUCTION 
Among human diseases, chronic renal failure (CRF) remains a serious health 
problem and the prevalence is increasing worldwide. Chronic renal failure is 
the most significant result of chronic kidney disease, characterized by a 
progressive loss of renal function. Damage to the kidneys over a period of 
ten years or more, may result in terminal kidney failure or end-stage renal 
disease (ESRD), which is the most feared consequence of kidney disease. 
According to Pierro et a/., (2001) the prevalence of ESRD is a good indicator 
of the burden of renal disease in a country. Therefore, ideally, effective 
programs should be directed at preventing the development of chronic renal 
insufficiency which could subsequent progress to ESRD. The early detection 
of kidney disease is very important. 
Prevention through early detection of kidney diseases may serve as a 
solution to reduce the prevalence of renal disease. Treatment at the earlier 
stages of kidney disease will arrest the progression of the established kidney 
disease or even l ead to the regression of the renal p arenchymal d amage. 
One epidemiological study suggested patients with kidney disease detected 
earlier had almost twice greater survival rate than those evaluated at a late 
stage (Mat Edelson, 2003). Unfortunately, many kidney diseases tended to 
be latent at onset and progress slowly making detection difficult. This is 
because kidneys have very high compensatory abilities that can compensate 
up to 70% loss of functional mass and this unique feature had contributed to 
the difficulty of detection of renal insufficiency at very early stages. 
At present, identification of patients with early renal disease relies heavily on 
blood and urine analysis in patients at increased risk for renal disease 
before the presence of significant symptoms. Analysis of urinary proteins 
and enzymes are accepted as reliable biomarkers and is very useful for the 
early diagnosis of tubule damage. 
Even though there are numerous studies on enzymuria and proteinuria, it 
seems there is lack of information on their correlation with renal disease 
especially at the early stages of renal damage. Hypothesis of this study is 
that there are correlation between proteinuria, enzymuria and renal 
histopathological changes during early renal damage. Thus, this study was 
undertaken to determine their correlation and consequently ascertain the 
earliest indicator of renal damage. Gentamicin, an aminoglycoside antibiotic 
was used as the inducer for renal damage in this study and its effects were 
assessed to determined: 
a. the relevant biochemical parameters that may be used as 
indicators of renal insufficiency during very early stage. 
b. the rate of excretion of selected serum and urine biochemical 
parameters (blood urea nitrogen, serum creatinine, electrolytes, 
protein, alkaline phosphatase, aspartate arninotransferase, gamma 
glutamyl transferase) during early renal damage. 
c. the correlation between the extent of renal damage and urinary 
enzyme and protein excretions. 
CHAPTER ll 
LITERATURE REVIEW 
Progressive Renal Disease 
Introduction 
The progressive loss of renal function to end-stage renal disease (ESRD) is 
a common p henomenon i n renal p atients i rrespective of the i nitial d isease 
(Mai et a/., 2000). The most important causes of ESRD, at least in the United 
States, were hypertension and diabetic nephropathy (Raine, 1994), which 
are reliable predictors of risk for kidney disease. Patients who recover from 
an episode of acute renal failure may be at risk of developing chronic renal 
disease (Salem, 1999). 
Nowadays, patients with various diabetic and non-diabetic glomerulopathies 
form the m ain contingent for renal replacement therapy (RRT) (Mai et a/., 
2000). The number of patients receiving dialysis and transplantation 
continues to increase (Carl, 1995). These therapies are expensive, so that 
prevention is of prime importance. Arresting the rate of the deterioration of 
kidney failure will have a great impact and this may be achieved through 
accurate detection of early abnormal renal changes (Mai et a/., 2000). 
Mechanisms 
The mechanism underlying progression of renal disease is likely to be 
multifactorial. The nature of the progressive renal damage with various 
etiologies is governed by such factors as hemodynamics, participation of the 
renin-ang iotensin system (RAS) and progressive proteinuria (Mai et a/. , 
2000). All histological manifestations from patients with impaired kidney 
function show a rather similar histological picture of glomerulosclerosis, 
interstitial fibrosis, tubular atrophy and an interstitial i nfiltration (Vleming et 
a/., 1999). These seem to suggest that the progressive loss of kidney 
function results from a pathologic process that serves as a final cascade of 
events before renal failure. These events may be independent of the original 
etiology of the disease (Vleming et a/., 1999). 
Disturbances in lipid metabolism, participation of cellular and molecular 
factors and subsequent accumulation of extra-cellular matrix component with 
- 
. the development of kidney fibrosis are closely related to the renal disease 
progression (Mai et a/., 2000). Recently much attention has been paid to the 
importance of persistence proteinuria, as an independent risk factor of renal 
disease progression (Giuseppe, 2000). There are now evidences which 
suggest a strong correlation between the degree of proteinuria and the rate 
of progression of renal failure in both diabetic (Breyer et a/., 1996) and non- 
diabetic (Ruggenenti et a/., 1998) renal disease patients. For 
also, the National Kidney Foundation (NFK) has recommended that high-risk 
individuals undergo routine screening for proteinuria (Verna, 1999). 
Treatment for Kidney Diseases 
Treatment of kidney diseases is a complex issue and depends on the type of 
disease, the underlying cause, and the duration of the diseases. Clinically it 
is important to differentiate acute renal failure (ARF) from chronic renal 
failure (CRF) because generally acute disease is potentially reversible while 
the chronic form is not. Unfortunately, ARF may eventually go on to develop 
into CRF or end-stage-renal-failure if no treatment is instituted. Up to 10% of 
patients who experience ARF will suffer irreversible renal failure (Paula, 
2000). 
Treatment usually starts with addressing the original causes. In the case of 
acute kidney failure, treating the underlying cause may return the kidneys to 
normal function. Normally, initial treatments are focused o n correcting fluid 
and electrolyte balances and uremia (Malay and Richard, 2000). Sometimes 
dietary restrictions (less salt and protein) are required until the kidneys are 
able to handle these substances. Diuretic drugs may help the body to 
excrete more water and salts. However, in CRF, drugs are used to stop the 
progression of the disease to ESRD. 
When kidney disease does not respond to treatment with dietary restrictions 
and drugs, dialysis or kidney transplantation are the next treatments to 
consider. At least 500 000 people throughout the world are being routinely 
maintained by renal dialysis (Pierro et a/., 2001). Dialysis is a technique used 
to remove waste products from the blood and excess fluids from the body of 
renal failure patients. Kidney transplantation on the other hand is a surgical 
procedure in which the diseased kidney is removed and replaced with a 
healthy kidney from a donor. This is the most effective form of renal disease 
therapy, with more than 12 000 procedures performed per year in the United 
State (David and Christopher, 1999). However, renal replacement therapy is 
expensive. 
New Therapeutic Strategies 
Renoprotection is a strategy, which has been developed to interrupt or 
reverse the progression of renal disease. Various modalities are now being 
used includes low-protein diet, anti-hypertensive therapy, and anti-fibrotic 
therapy (Mai et a/., 2000). However, it seems that the benefit of a low-protein 
diet in slowing the progression of renal failure is negligible (Pierro et a/., 
2001). Instead an adequate early anti-proteinuric therapy may be a better 
approach. Anti-proteinuric therapy may arrest the progression of the renal 
disease or even lead to regression of the disease (Mai eta/., 2002). 
Hypertension is recognized to be a strong independent risk factor for ESRD 
(Klag et a/., 1996). Renoprotection through lowering the blood pressure 
uniformly has shown to slow the disease progression and reduces renal 
damage (Anderson et a/., 1986). Among the anti-hypertensive drugs, the 
angiotensin-converting-enzyme (ACE) inhibitors are most effective in 
